Is Telix (ASX:TLX) Using Theranostic Alliances To Deepen Its Neuro-Oncology Moat?

Simply Wall St.

Jun 21

In recent days, Telix Pharmaceuticals and United Imaging Healthcare signed a memorandum of understanding for a research collaboration in the US to combine United Imaging’s advanced scanner, software ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2645286097"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2645286097\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2645286097?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","is_english":true,"pubTime":"2026-06-21 17:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2645286097","market":"nz","top_or_hot":-1,"title":"Is Telix (ASX:TLX) Using Theranostic Alliances To Deepen Its Neuro-Oncology Moat?","media":"Simply Wall St.","content":"<div>\n<p>In recent days, Telix Pharmaceuticals and United Imaging Healthcare signed a memorandum of understanding for a research collaboration in the US to combine United Imaging’s advanced scanner, software ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/is-telix-asxtlx-using-theranostic-alliances-to-deepen-its-ne\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Telix (ASX:TLX) Using Theranostic Alliances To Deepen Its Neuro-Oncology Moat?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Telix (ASX:TLX) Using Theranostic Alliances To Deepen Its Neuro-Oncology Moat?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-21 17:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/is-telix-asxtlx-using-theranostic-alliances-to-deepen-its-ne><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In recent days, Telix Pharmaceuticals and United Imaging Healthcare signed a memorandum of understanding for a research collaboration in the US to combine United Imaging’s advanced scanner, software ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/is-telix-asxtlx-using-theranostic-alliances-to-deepen-its-ne\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TLX.AU","symbol_name":"TELIX PHARMACEUTICALS LTD","start_time":0,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/is-telix-asxtlx-using-theranostic-alliances-to-deepen-its-ne","article_id":"2645286097","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/is-telix-asxtlx-using-theranostic-alliances-to-deepen-its-ne","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2645286097","pubTimestamp":1782033690,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"In recent days, Telix Pharmaceuticals and United Imaging Healthcare signed a memorandum of understanding for a research collaboration in the US to combine United Imaging’s advanced scanner, software and AI platforms with Telix’s molecular imaging products, initially centred on TLX101-Px for characterizing recurrent or progressive glioma under FDA review.\nThis alliance underscores Telix’s push to integrate its radiopharmaceutical pipeline with cutting-edge imaging hardware and clinical...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"TLX.AU":"TELIX PHARMACEUTICALS LTD","BK7067":"生物科技","BK4139":"生物科技","TLX":"Telix Pharmaceuticals Ltd. (Uplisting)"},"translate_title":"Telix(ASX：TLX)是否正在利用治疗诊断联盟来加深其神经肿瘤护城河？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TLX.AU":1,"TLX":1.5},"content_text":"In recent days, Telix Pharmaceuticals and United Imaging Healthcare signed a memorandum of understanding for a research collaboration in the US to combine United Imaging’s advanced scanner, software and AI platforms with Telix’s molecular imaging products, initially centred on TLX101-Px for characterizing recurrent or progressive glioma under FDA review. This alliance underscores Telix’s push to integrate its radiopharmaceutical pipeline with cutting-edge imaging hardware and clinical workflows, potentially enhancing how clinicians use molecular imaging to guide patient management in neuro-oncology and other tumor settings. We’ll now explore how this new theranostics-focused collaboration around TLX101-Px could influence Telix Pharmaceuticals’ broader investment narrative and growth priorities. We've uncovered the 7 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.AdvertisementTelix Pharmaceuticals Investment Narrative RecapTo own Telix, you need to believe its radiopharmaceutical platform can translate imaging leadership into a meaningful theranostics business, underpinned near term by Illuccix and Gozellix and, potentially, TLX101-Px approval. The United Imaging collaboration looks directionally positive for that thesis but does not change the most important short term catalyst, which remains the FDA decision on TLX101-Px, nor the biggest current risk around pricing and margin pressure in PSMA imaging and TMS operations. In this context, the most relevant recent announcement is the FDA’s acceptance of Telix’s resubmitted TLX101-Px NDA, with a PDUFA goal date of 11 September 2026. The United Imaging research tie-up now sits alongside that regulatory milestone, giving TLX101-Px an emerging ecosystem of imaging, software and AI support. Together, they frame how investors might think about Telix’s next inflection point in neuro-oncology as part of a broader theranostics story. Yet, even if Telix executes on these opportunities, investors should still be aware of how prolonged SEC scrutiny around disclosure practices could... Read the full narrative on Telix Pharmaceuticals (it's free!)Telix Pharmaceuticals' narrative projects $1.2 billion revenue and $111.3 million earnings by 2029. This requires 22.7% yearly revenue growth and about a $100.5 million earnings increase from $10.8 million today.Uncover how Telix Pharmaceuticals' forecasts yield a A$25.14 fair value, a 73% upside to its current price.Exploring Other PerspectivesASX:TLX 1-Year Stock Price Chart Some of the lowest ranked analysts were already assuming about A$1.2 billion of revenue and no profits within three years, and they worry that even with collaborations like United Imaging, intensifying PSMA pricing and execution risks in the TMS build out could keep margins thin and push out the payoff from theranostics, which shows how far opinions can differ and why it helps to weigh several viewpoints before you decide what you think.Explore 20 other fair value estimates on Telix Pharmaceuticals - why the stock might be worth over 2x more than the current price!Reach Your Own ConclusionDon't just follow the ticker - dig into the data and build a conviction that's truly your own.A great starting point for your Telix Pharmaceuticals research is our analysis highlighting 3 key rewards that could impact your investment decision.Our free Telix Pharmaceuticals research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Telix Pharmaceuticals' overall financial health at a glance.Ready To Venture Into Other Investment Styles?Every day counts. These free picks are already gaining attention. See them before the crowd does:Explore 31 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.The future of work is here. Discover the 31 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Telix Pharmaceuticals might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}